Cognitive aging
Can ML flag high-risk AS+HFpEF after TAVR?
Open access · cc by · source: Europe PMC
In 326 TAVR patients, an 8-feature SVM reached validation AUC 0.756 for 12-month MACCE, explained with SHAP.
Study at a glance
- Design
- Cohort — Multicenter retrospective TAVR cohort with train/validation ML risk models
- N
- N=326 · 195 derivation + 131 external validation patients
- Population
- Older patients with severe aortic stenosis and HFpEF undergoing TAVR
- Outcome
- 12-month major adverse cardiovascular and cerebrovascular events predicted by explainable ML
Structured fields used in claim comparison tables when every cited study has a complete layer.
Key findings
SVM performed best (AUC 0.756); features centered on age, NT-proBNP, and metabolic lipid-glucose indices; good calibration/net benefit claimed vs alternatives.
Methodology
Selected features via LASSO+Boruta, trained five ML models on 195 patients, validated on 131 from other hospitals, and interpreted with SHAP.
Limitations
Prospective deployment benefit, or psychology-primary mechanisms (cardiac cohort framed for aging risk markers).
How this study connects
Role on claims
Each row is a claim on a concept or method page where this paper supports, challenges, or qualifies the statement. Roles are hand-checked — not a model guess.
Not yet placed on a claim. This paper has study layers, but no concept page yet cites it as support, challenge, or qualifier.
Related papers in this topic
Same topic cluster — not a recommendation engine.